Natur Produkt International JSCis the latest consumer health acquisition for Valeant Pharmaceuticals International Inc., which announced its $180 million purchase of the Russian OTC company March 26. St. Petersburg-based Natur Produkt generated revenue of about $65 million in 2011 and is poised for double-digit growth in 2012, boosted by sales of the AntiGrippin cough/cold remedy brand Valeant said. The acquisition, which includes an additional $5 million in potential future milestone payments, is expected to close by mid-2012 and will be accretive immediately for Mississauga, Ontario-based Valeant. The Russian OTC market is proving attractive to pharma companies, including Johnson & Johnson Also see "J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition" - Pink Sheet, 30 May, 2011..
Nicox SA acquires 11.8% of privately held U.K. ophthalmology business Altacor Ltd. for £2 million ($3.2 million on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?